Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 6/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | STAT6 | P42226 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dehydrocostuslactone SCHEMBL31029489 | 1.00 | CYP19A1 (0.46) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| Dehydrocostuslactone SCHEMBL936050 | 1.00 | CYP19A1 (0.46) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| Dehydrozaluzanin C SCHEMBL17214360 | 0.83 | CYP19A1 (0.42) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| Isozaluzanin C SCHEMBL24453721 | 0.80 | PKM (0.40) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| Isozaluzanin C SCHEMBL17214374 | 0.80 | PKM (0.40) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| Eremanthin SCHEMBL9516039 | 0.79 | CYP19A1 (0.56) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| SCHEMBL22305504 | 0.73 | PTGS2 (0.40) | CYP19A1PKMNLRP3CYP3A4PTGS2 | |
| SCHEMBL22305507 | 0.72 | PKM (0.41) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| SCHEMBL17147746 | 0.71 | PKM (0.55) | CYP19A1PKMNLRP3ALDH1A1LMNA | |
| SCHEMBL17147754 | 0.71 | PKM (0.55) | CYP19A1PKMNLRP3ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 748 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122084810-A | Establishing method of fingerprint spectrum of oil for inducing resuscitation and saving heart and detecting method of component content | — | 2026-05-26 | — | — | CN | claimed |
| CN-122005545-A | Application of dehydrocostuslactone and medicine for treating steatohepatitis | 国科温州研究院(温州生物材料与工程研究所) | 2026-05-12 | — | — | CN | claimed |
| US-20260124203-A1 | CHEMICAL SYNTHETIC LETHALITY FOR ANTIMICROBIAL THERAPY | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2026-05-07 | — | — | US | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| CN-118731248-B | Establishment method and application of reference GC-MS fingerprint of Juanbi decoction substance | 广西中医药大学百年乐制药有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119881160-A | Method for measuring content of 8 chemical components in spleen-invigorating pill and fingerprint method thereof | 上海和黄药业有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119804722-A | Method for measuring contents of seven active ingredients in ancient classical prescription of Xiangsha Liujunzi decoction | 浙江省肿瘤医院 | 2025-04-11 | — | — | CN | claimed |
| CN-119462620-B | Dehydrocostuslactone derivative and preparation method and application thereof | 四川大学华西医院 | 2025-04-04 | — | — | CN | claimed |
| CN-118717785-B | Pharmaceutical composition for preventing and treating scar hyperplasia and preparation method and application thereof | 威海人生药业有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-115963220-B | Identification method of stomach ache pill | 广州白云山中一药业有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-101007044-B | A medicine composition for treating peptic ulcer, preparing method and use thereof | UNIV CHENGDU TRAD CN MEDICINE | 2010-06-09 | — | — | CN | claimed |
| CN-101559192-A | Traditional Chinese medicine granular formulation for warming stomach and regulating middle warmer and quality control method thereof | BEIJING ASIA EAST BIO PHARM CO (CN) | 2009-10-21 | — | — | CN | claimed |
| CN-101357151-A | Method for extracting total lactones from auckandia root and quality control method thereof | MINGHAI LI (CN) | 2009-02-04 | — | — | CN | claimed |
| CN-101342214-A | Banksia rose total lactone medicament composition and preparation method thereof | MINGHAI LI (CN) | 2009-01-14 | — | — | CN | claimed |
| CN-101342215-A | Banksia rose capsule, preparation method and quality control method thereof | LI MINGHAI (CN) | 2009-01-14 | — | — | CN | claimed |
| CN-101317872-A | Traditional Chinese medicine oral preparation for treating functional dyspepsia | TIANJIN DANXI NAT MEDICINES IN (CN) | 2008-12-10 | — | — | CN | claimed |
| CN-101172135-A | Medicament for promoting stomach and intestine function or liveness and application of its components composition | RENBING SHI (CN) | 2008-05-07 | — | — | CN | claimed |
| CN-101073590-A | Muxiang total lactone extract and its production | SHI RENBING (CN) | 2007-11-21 | — | — | CN | claimed |
| CN-101007044-A | A medicine composition for treating peptic ulcer, preparing method and use thereof | CHENGDU UNIVERSITY OF TRADITIO (CN) | 2007-08-01 | — | — | CN | claimed |
| CN-1981861-A | Yixinkang preparation for treating cardiovascular and cerebrovascular diseases and its quality controlling method | QIYUANYIDE DRUG INST BEIJING (CN) | 2007-06-20 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124203-A1 | CHEMICAL SYNTHETIC LETHALITY FOR ANTIMICROBIAL THERAPY | COASY, GLO1, FARS2 | CYP19A1 1365/4885PKM 1863/4885NLRP3 1348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.